Nycomed Amersham Imaging taps CEO
Anglo-Norwegian pharmaceutical company Nycomed Amersham of Buckinghamshire, U.K., has tapped John Padfield as CEO of its Nycomed Amersham Imaging contrast division. Padfield joins the company from U.K. pharmaceutical firm Chiroscience Group and
Anglo-Norwegian pharmaceutical company Nycomed Amersham of Buckinghamshire, U.K., has tapped John Padfield as CEO of its Nycomed Amersham Imaging contrast division. Padfield joins the company from U.K. pharmaceutical firm Chiroscience Group and will succeed Guy Marlow as chief of Nycomed Amershams global contrast business. Marlow is retiring later this year.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
